Vraylar (cariprazine)

pCPA File Number: 21973

Negotiation Status:

Concluded with an LOI

Indication(s):

schizophrenia in adults

Sponsor/Manufacturer:

AbbVie Corporation

CDA-AMC Project Number:

SR0708

pCPA Engagement Letter Issued:

2023-01-25

Negotiation Process Concluded:

2023-03-28